- Home
- KNSA vs BAK Comparison
KNSA vs BAK Comparison
Compare KNSA & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- BAK
- Stock Information
- Founded
- KNSA 2015
- BAK 1972
- Country
- KNSA United Kingdom
- BAK Brazil
- Employees
- KNSA N/A
- BAK N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- BAK Major Chemicals
- Sector
- KNSA Health Care
- BAK Industrials
- Exchange
- KNSA Nasdaq
- BAK Nasdaq
- Market Cap
- KNSA 2.1B
- BAK 1.4B
- IPO Year
- KNSA 2018
- BAK N/A
- Fundamental
- Price
- KNSA $27.88
- BAK $3.41
- Analyst Decision
- KNSA Strong Buy
- BAK Strong Buy
- Analyst Count
- KNSA 5
- BAK 3
- Target Price
- KNSA $38.80
- BAK $9.75
- AVG Volume (30 Days)
- KNSA 1.1M
- BAK 799.3K
- Earning Date
- KNSA 07-22-2025
- BAK 08-06-2025
- Dividend Yield
- KNSA N/A
- BAK N/A
- EPS Growth
- KNSA N/A
- BAK N/A
- EPS
- KNSA N/A
- BAK N/A
- Revenue
- KNSA $481,166,000.00
- BAK $13,770,122,923.00
- Revenue This Year
- KNSA $37.21
- BAK $18.11
- Revenue Next Year
- KNSA $5.32
- BAK $7.32
- P/E Ratio
- KNSA N/A
- BAK N/A
- Revenue Growth
- KNSA 59.45
- BAK 14.35
- 52 Week Low
- KNSA $17.82
- BAK $2.85
- 52 Week High
- KNSA $30.69
- BAK $7.71
- Technical
- Relative Strength Index (RSI)
- KNSA 50.38
- BAK 44.84
- Support Level
- KNSA $26.89
- BAK $3.27
- Resistance Level
- KNSA $27.97
- BAK $3.87
- Average True Range (ATR)
- KNSA 0.95
- BAK 0.12
- MACD
- KNSA -0.27
- BAK -0.02
- Stochastic Oscillator
- KNSA 48.73
- BAK 35.21
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.